Results 81 to 90 of about 63,993 (197)
Pharmacovigilance [Pharmacovigilance update]
The observations of pharmacovigilance reported during 2007 reflect an increasing attention towards drug-induced augmentation of the incidence of common disorders. New substances are thus to be added to the list of risk factors susceptible to favour cardiovascular events (tegaserod, rosiglitazone, erythropoïetin, aprotinine) or psychiatric disorders ...
Livio, F., Buclin, T., Biollaz, J.
openaire +1 more source
Background The benefit-risk balance of vaccines is regularly debated by the public, but the utility of media monitoring for regulatory bodies is unclear.
Priya Bahri +4 more
doaj +1 more source
Learning signals of adverse drug-drug interactions from the unstructured text of electronic health records. [PDF]
Drug-drug interactions (DDI) account for 30% of all adverse drug reactions, which are the fourth leading cause of death in the US. Current methods for post marketing surveillance primarily use spontaneous reporting systems for learning DDI signals and ...
Bauer-Mehren, Anna +4 more
core +5 more sources
Strengthening Pharmacovigilance System to Capture Safety Data from HIV Clients on ART in Tanzania: Identification of Gaps in Safety Reporting System [PDF]
In Tanzania, pharmacovigilance system is implemented by Tanzania Food and Drugs Authority (TFDA) that monitors drug use countrywide. TFDA is the main national custodian for recording, analyzing and disseminating safety information that is generated ...
Baraka, Vito +9 more
core
Pharmacovigilance: Scope for a dermatologist
Pharmacovigilance is defined as the science of detection, assessment, and prevention of adverse drug reactions in humans. Under-reporting of drug reactions is the major problem and has various reasons. The WHO has initiated the program of reporting all adverse drug reactions now co-ordinated by the Uppsala Monitoring Centre in Uppsala, Sweden, with ...
Bhanu Prakash, Gurcharan Singh
openaire +3 more sources
Introduction Estimating respiratory syncytial virus (RSV) burden in adults is challenging because of non-specific symptoms, infrequent standard-of-care testing, resolution of viral shedding before seeking medical care, test positivity that varies by ...
Robin Bruyndonckx +6 more
doaj +1 more source
Classification of existing problems in the Russian pharmacovigilance system
The pharmacovigilance system currently represents as a complex of interstate, state, departmental and public institutions. This system provides the receipt and processing of information about facts and circumstances that pose a threat to life or health ...
B. K. Romanov, A. E. Krasheninnikov
doaj +1 more source
Global challenges of graduate level Ayurvedic education: A survey [PDF]
In the present day scenario, Ayurveda is globally being perceived in several contradictory ways. Poor quality of Ayurveda graduates produced as a result of poorly structured and poorly regulated education system is at least one of the important factors ...
Gehlot, Dr. Sangeeta +3 more
core
Pharmacovigilance update [Pharmacovigilance update]
Main pharmacovigilance signals and alerts issued in 2009 are reviewed. Efalizumab was withdrawn from the market due to increased risks, including progressive multifocal leukoencephalopathy (PML) and questionable efficacy. New cases of PML are still being reported with rituximab and natalizumab.
Livio, F. +4 more
openaire +1 more source
Adverse Drug Reaction Classification With Deep Neural Networks [PDF]
We study the problem of detecting sentences describing adverse drug reactions (ADRs) and frame the problem as binary classification. We investigate different neural network (NN) architectures for ADR classification.
He, Yulan +3 more
core +1 more source

